Home
Heron Therapeutics HRTX paid Farragut Partners $50K for lobbying in Q4 2022 · Health Issues, Medicare
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q4 2022
- Client
- Heron Therapeutics
- Reported
- 23/01/20
$50K on lobbying in 2022
What else happened in Heron Therapeutics around then
Filed or reported within 30 days of the trade day · 22/12/01~23/01/30Heron Therapeutics's other lobbying reports
- Heron Therapeutics
LobbyingHeron Therapeutics
LobbyingHeron Therapeutics
HRTX
$50K
$50K
Reported 07/20
for Q2
- Heron Therapeutics
LobbyingHeron Therapeutics
LobbyingHeron Therapeutics
HRTX
$50K
$50K
Reported 04/20
for Q1
- Heron Therapeutics
LobbyingHeron Therapeutics
LobbyingHeron Therapeutics
HRTX
$50K
$50K
Reported 01/20
for Q4 2025
- Heron Therapeutics
LobbyingHeron Therapeutics
LobbyingHeron Therapeutics
HRTX
$50K
$50K
Reported 25/10/20
for Q3 2025
- Heron Therapeutics
LobbyingHeron Therapeutics
LobbyingHeron Therapeutics
HRTX
$50K
$50K
Reported 25/07/21
for Q2 2025